Skip to content

Clinical trials

Phase 2 Carcinoma, Hepatocellular trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Country / region: Germany Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20063
20071
20082
20094
20103
20113
20121
20132
20141
20182
20194
20204
20213
20221
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting4
Terminated4
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest6
University of Magdeburg2
4SC AG1
AIO-Studien-gGmbH1
Astellas Pharma Inc1
Auron Healthcare GmbH1
BeiGene1
Boehringer Ingelheim1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular41
Liver Neoplasms6
Cholangiocarcinoma3
Colorectal Neoplasms2
Gallbladder Neoplasms2
Ovarian Neoplasms2
Urinary Bladder Neoplasms2
Bile Duct Neoplasms1
Biliary Tract Neoplasms1
Breast Neoplasms1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.